Alert detail
LCD L36117: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease — CGS
What changed
New genetic testing LCD affects billing for myeloproliferative disease.
Who’s affected: Hematology billing teams · Effective: May 15, 2025
Affected codes
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
This change affects 17 billing codes.
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.